These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17907570)

  • 1. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in oncoproteomics.
    Jain KK
    Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology in clinical proteomics.
    Geho DH; Luchini A; Garaci E; Belluco C; Petricoin E; Liotta LA
    Nanomedicine (Lond); 2007 Feb; 2(1):1-5. PubMed ID: 17716185
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
    Niu D; Feng H; Chen WN
    J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inconvenient truth: cancer biomarker development by using proteomics.
    Kondo T
    Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of serum proteomics for detection of cancer: promise or only hope?
    Krueger KE
    Onkologie; 2006 Nov; 29(11):498-9. PubMed ID: 17068383
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Array-based Approaches for Biomarker Discovery in Cancer.
    Huang Y; Zhu H
    Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):73-81. PubMed ID: 28392481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of cancer biomarkers.
    Shau H; Chandler GS; Whitelegge JP; Gornbein JA; Faull KF; Chang HR
    Brief Funct Genomic Proteomic; 2003 Jul; 2(2):147-58. PubMed ID: 15239937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
    Clarke W; Chan DW
    Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of Serial Analysis of Gene Expression in cancer research.
    Yamashita T; Honda M; Kaneko S
    Curr Pharm Biotechnol; 2008 Oct; 9(5):375-82. PubMed ID: 18855690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies.
    Gulcicek EE; Colangelo CM; McMurray W; Stone K; Williams K; Wu T; Zhao H; Spratt H; Kurosky A; Wu B
    Curr Protoc Bioinformatics; 2005 Jul; Chapter 13():Unit 13.1. PubMed ID: 18428746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of cancer of hormone-dependent tissues.
    Tyson DR; Ornstein DK
    Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of advanced proteomics technologies to cancer diagnosis.
    Ciordia S; de Los Ríos V; Albar JP
    Clin Transl Oncol; 2006 Aug; 8(8):566-80. PubMed ID: 16952845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics for cancer biomarker discovery.
    Srinivas PR; Verma M; Zhao Y; Srivastava S
    Clin Chem; 2002 Aug; 48(8):1160-9. PubMed ID: 12142368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.